Stockscreener 앱 받기
105.10
1.26%
1.3142
전일 마감가:
$103.79
열려 있는:
$104.85
하루 거래량:
2.67M
Relative Volume:
0.49
시가총액:
$153.75B
수익:
$16.75B
순이익/손실:
$1.85B
주가수익비율:
84.08
EPS:
1.25
순현금흐름:
$2.37B
1주 성능:
+0.67%
1개월 성능:
+1.96%
6개월 성능:
+29.52%
1년 성능:
+56.55%
1일 변동 폭
$103.83
$105.57
1주일 범위
$97.08
$105.57
52주 변동 폭
$65.52
$107.17
보스턴사이언티픽 Stock (BSX) Company Profile
명칭
Boston Scientific Corp
전화
508-683-4000
주소
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
BSX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
105.03 | 153.75B | 16.75B | 1.85B | 2.37B | 1.25 |
|
ABT
Abbott Laboratories
|
140.22 | 241.69B | 41.95B | 13.40B | 6.35B | 7.65 |
|
SYK
Stryker Corp
|
395.85 | 150.24B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
94.40 | 120.56B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.40 | 42.42B | 5.72B | 4.17B | 490.10M | 6.97 |
보스턴사이언티픽 Stock (BSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-10-18 | 다운그레이드 | Needham | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-02-01 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-06-30 | 개시 | CL King | Buy |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-12-22 | 개시 | Mizuho | Neutral |
| 2022-12-20 | 재개 | Citigroup | Buy |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-06 | 개시 | Wolfe Research | Outperform |
| 2022-05-27 | 업그레이드 | Needham | Hold → Buy |
| 2022-04-13 | 재개 | Truist | Buy |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-05-26 | 다운그레이드 | Needham | Buy → Hold |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2020-09-17 | 개시 | Truist | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-04-22 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Buy |
| 2019-12-30 | 재확인 | Cowen | Outperform |
| 2019-12-19 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-09-05 | 재개 | JP Morgan | Overweight |
| 2019-09-03 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 개시 | UBS | Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-10-02 | 재확인 | Morgan Stanley | Overweight |
| 2018-09-07 | 재확인 | Needham | Strong Buy |
| 2018-09-04 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-07-06 | 재확인 | Needham | Strong Buy |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-04-26 | 재확인 | Needham | Strong Buy |
모두보기
보스턴사이언티픽 주식(BSX)의 최신 뉴스
Boston Scientific makes second acquisition for $360M upfront - The Business Journals
Boston Scientific To Acquire SoniVie For $400 Million, Expanding Hypertension Treatment Portfolio - Benzinga
Boston Scientific to Purchase SoniVie Ltd. - MPO-mag
Boston Scientific to acquire renal denervation company SoniVie - Mass Device
Boston Scientific Announces Agreement To Acquire Sonivie Ltd -March 03, 2025 at 08:55 am EST - Marketscreener.com
Boston Scientific To Buy SoniVie For Upfront Payment Of Approx. $360 Mln - Nasdaq
Boston Scientific announces agreement to acquire SoniVie Ltd. - Quantisnow
The Zacks Analyst Blog The Goldman Sachs, The Progressive, Boston Scientific and Cooper-Standard - Zacks Investment Research
Cavalier Investments LLC Raises Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Bank of New York Mellon Corp Has $1.11 Billion Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Top Stock Reports for Goldman Sachs, Progressive & Boston Scientific - Yahoo Finance
Boston Scientific Stock Price | BSX Stock Quote, News, and History - Markets Insider
Insider Selling: Boston Scientific Co. (NYSE:BSX) EVP Sells 4,675 Shares of Stock - MarketBeat
Consilium Wealth Advisory LLC Raises Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
April 11th Options Now Available For Boston Scientific (BSX) - Nasdaq
Boston Scientific Corporation (BSX): Among Stocks to Invest In from Israel Englander’s Portfolio - Insider Monkey
Boston Scientific Co. (NYSE:BSX) Shares Acquired by Alecta Tjanstepension Omsesidigt - MarketBeat
New York Life Investment Management LLC Raises Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Fisher Funds Management LTD Buys New Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Co. (NYSE:BSX) Stake Raised by HealthInvest Partners AB - MarketBeat
Boston Scientific Announces Completion Of EUR1.5 Billion Offering Of Senior Notes - Marketscreener.com
Boston Scientific announces completion of €1.5 billion offering of senior notes - Quantisnow
Catheter Market Global Report and Company Analysis 2025-2033 Featuring Abbott Laboratories, BD and Co, Boston Scientific, Teleflex, Medtronic, Johnson & Johnson, Edwards Lifesciences, Stryker - Yahoo Finance
Atria Wealth Solutions Inc. Boosts Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific’s SWOT analysis: innovative medtech stock poised for growth - Investing.com
$1000 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today - Benzinga
Boston Scientific Recalls Accolade Pacemaker Devices - The Rochester Sentinel
Boston Scientific reports first cases with next-gen Faraflex catheter - Mass Device
Boston Scientific Co. (NYSE:BSX) Stock Position Lessened by Bradley Foster & Sargent Inc. CT - MarketBeat
Boston Scientific director Zane Ellen M sells $1.42 million in stock By Investing.com - Investing.com South Africa
StockNews.com Downgrades Boston Scientific (NYSE:BSX) to Hold - MarketBeat
Boston Scientific director Zane Ellen M sells $1.42 million in stock - Investing.com India
Boston Scientific Director Sells Over $1.4 Million in Company Stock - TradingView
Boston Scientific Loses Patent For Flexible Stent On Appeal - Law360
Boston Scientific prices $1.6B public offering - Mass Device
Balloon Catheters Patent Landscape Report 2025, with - GlobeNewswire
Balloon Catheters Patent Landscape Report 2025, with Profiles of Cook Medical Technologies, Boston Scientific Scimed, Scimed Life Systems, Terumo Corp and Advanced Cardiovascular System - Yahoo Finance
What Does the Market Think About Boston Scientific? - Benzinga
Truist Financial Corp Sells 4,801 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific's SVP Vance Brown sells $504,992 in stock By Investing.com - Investing.com Australia
TKG Advisors LLC Boosts Stock Position in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Announces Pricing Of EUR1.5 Billion Of Senior Notes -February 22, 2025 at 03:16 am EST - Marketscreener.com
Boston Scientific Co. (NYSE:BSX) Shares Sold by New York State Common Retirement Fund - MarketBeat
Boston Scientific announces pricing of €1.5 billion of senior notes - The Malaysian Reserve
Boston Scientific's American Medical Systems Europe Prices EUR 1.5 Bln Of Senior Notes - Nasdaq
Boston Scientific raises €1.5bn after double upgrade - GlobalCapital
Boston Scientific's SVP Vance Brown sells $504,992 in stock - Investing.com India
Boston Scientific’s SVP Vance Brown sells $504,992 in stock By Investing.com - Investing.com Nigeria
BSX: 3 Medical Device Stocks Seeing Surge in Demand - StockNews.com
FDA Boston Scientific Corporation Recalls Accolade Pacemaker Devices Due To Manufacturing Issue That May Lead To Early Device Replacement - Marketscreener.com
Boston Scientific hired 5,000 new employees, increased real estate footprint in 2024 - NBC Boston
보스턴사이언티픽 (BSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.52%
자본화:
|
볼륨(24시간):